Singh, S., Bliden, K., Tantry, U. S., Gurbel, P. A., Kanjwal, M. Y., & Lundgren, S. W. (2025). Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction. Am J Cardiol, 235, 73–75. https://doi.org/10.1016/j.amjcard.2024.10.027

Singh, Sahib, Kevin Bliden, Udaya S. Tantry, Paul A. Gurbel, Mohammed Y. Kanjwal, and Scott W. Lundgren. “Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction.” Am J Cardiol 235 (January 15, 2025): 73–75. https://doi.org/10.1016/j.amjcard.2024.10.027.

Singh S, Bliden K, Tantry US, Gurbel PA, Kanjwal MY, Lundgren SW. Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction. Am J Cardiol. 2025 Jan 15;235:73–5.

Singh, Sahib, et al. “Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction.” Am J Cardiol, vol. 235, Jan. 2025, pp. 73–75. Pubmed, doi:10.1016/j.amjcard.2024.10.027.

Singh S, Bliden K, Tantry US, Gurbel PA, Kanjwal MY, Lundgren SW. Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction. Am J Cardiol. 2025 Jan 15;235:73–75.